Ascensia Diabetes Care and Senseonics Launch “The CGM for Real Life” Campaign to Empower People with Diabetes

Ascensia Diabetes Care and Senseonics Holdings Inc. have joined forces to introduce their new advertising and marketing campaign, “The CGM for Real Life,” aimed at raising awareness about the Eversense E3 CGM System. This innovative continuous glucose monitoring (CGM) system is designed to cater to the everyday needs of individuals living with diabetes.

Managing diabetes can be a complex task, and CGMs have become an essential tool for the 37 million people living with diabetes in the United States. However, nearly half of the users of the two most commonly known CGM brands are not fully satisfied with their current systems. Many individuals take breaks from CGMs due to issues such as sensors falling off prematurely or discomfort caused by having a device attached to their body.

The Eversense E3 CGM System stands out as the longest-lasting CGM available, with a sensor wear duration of six months and only two sensor insertion and removal procedures required per year. The “The CGM for Real Life” campaign aims to showcase the unique benefits of Eversense E3, emphasizing its unparalleled flexibility and long-term use that seamlessly integrates into real-life scenarios.

Rudy Thoms, VP, CGM Commercial U.S. of Ascensia Diabetes Care, expressed excitement about challenging the status quo in continuous glucose monitoring. He believes that Eversense has the potential to be a game-changer for people with diabetes, and this campaign will help bring it to the attention of a wider audience.

Chris Ruden, a Keynote Speaker and Eversense Brand Ambassador, shared his personal struggle with short-term CGMs and how Eversense has seamlessly integrated into his busy life. Once inserted, Eversense allows him to forget about the hassle of replacements for six months, enabling him to focus on his daily activities without diabetes getting in the way.

“The CGM for Real Life” campaign is a coordinated effort to raise awareness about Eversense E3 directly among U.S. consumers. It marks the first time the brand is launching a campaign across connected TV and linear TV in five states, in addition to digital and social media platforms. The goal is to inform people with diabetes and healthcare professionals about the unique benefits of Eversense E3.

Physicians, nurse practitioners, and physician assistants interested in offering the Eversense E3 CGM System can sign up on the website provided. For more information about the safety of the Eversense E3 CGM System, visit the Ascensia Diabetes Care website.

Ascensia Diabetes Care, a subsidiary of PHC Holdings Corporation, and Senseonics Holdings Inc. are committed to empowering individuals with diabetes through advanced CGM technology. With the launch of “The CGM for Real Life” campaign, they aim to revolutionize the way people manage their diabetes, providing them with a reliable and long-lasting solution.